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Abstract 
Background: There is variable cardiac uptake observed on oncological 18F-fludeoxyglucose ([18F]FDG) positron emission/com-
puted tomography (PET/CT). The main purpose of this study is to evaluate patterns of overnight fasting myocardial [18F]FDG 
uptake in oncological PET/CT and analyse the relationship between myocardial [18F]FDG uptake and myocardial ischaemia 
on stress single-photon emission CT (SPECT) myocardial perfusion imaging (MPI).   
Material and methods: A total of 362 subjects underwent both oncological PET/CT and stress SPECT MPI within 3 months of 
each other. Subjects with focal-mass-like [18F]FDG myocardial uptake raising the suspicion of cardiac metastasis and subjects 
with coronary artery disease (CAD) were excluded. The myocardial [18F]FDG uptake was classified into four patterns.
Results: Abnormal SPECT MPI was noted in 91 (25%) patients; 220 (61%) patients had completely absent [18F]FDG uptake, 
80 (22%) had diffuse [18F]FDG uptake, 39 (11%) had focal on diffuse [18F]FDG uptake, and 23 (6%) had focal or regional myo-
cardial [18F]FDG uptake, the regional [18F]FDG myocardial uptake was the most predictive of myocardial ischaemia on SPECT 
MPI, and there were positive associations between age, sex, hypertension, tobacco smoking, hypercholesterolemia, and left 
ventricular ejection,  a fair agreement was noted between the focal or regional FDG uptake and presence of ischaemia on 
SPECT, K = 0.394 (95% CI 0.164 to 0.189).
Conclusions: Based on the presented findings, the physiological myocardial [18F]FDG uptake in fasting oncology patients is 
variable. The regional myocardial [18F]FDG uptake pattern is the most frequent pattern associated with myocardial ischaemia 
on stress SPECT MPI, however, the agreement between regional FDG uptake and presence of ischaemia on SPECT is fair. 
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Introduction
While normal myocardial 18F-fludeoxyglucose ([18F]FDG) activity 
can be defined as absent or diffusely, focally, or regionally increased, 
myocardial [18F]FDG uptake in oncology patients is non-uniform and 
variable [1]. There is high spatial and temporal heterogeneity of the 
[18F]FDG myocardial metabolism patterns in cancer patients free 
of cardiac disease [2]. This variability may occur in daily cardiac 
evaluation, and it may affect the interpretation of cardiac studies in 
certain disease evaluations, such as cardiac sarcoidosis and my-
ocardial viability [3]. Some data suggest that metabolic alteration 
may occur in oncology patients; for example, metabolic alteration 
in cardiac glucose uptake may arise in patients with Hodgkin’s lym-
phoma independent of skeletal muscle uptake [4]. The regional 
myocardial uptake in patients with stable angina is homogenously 
low and comparable to that of healthy subjects [5]. However, in 
patients with ischaemic cardiomyopathy or severe re-perfused 
myocardial injury, the myocardial utilization at rest is increased 
because the oxidative metabolism is reduced. In this case, to 
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support adenosine triphosphate production from glycolysis, the 
primary substrate of energy metabolism becomes glucose [6, 7].
Studies have also shown that, in patients with severe coronary 
artery disease (CAD) and unstable angina, myocardial glucose 
utilization is enhanced in the absence of clinical, electrocardio-
graphic, or detectable perfusion evidence of acute ischaemia [8]. 
Also, studies have shown that patients with clinical suspicion of 
CAD have a higher incidence of focal myocardial uptake and cor-
onary artery calcification but the FDG uptake is often observed in 
sites remote from those with calcification [9]. However, it is difficult 
to diagnose the presence of an ischaemic myocardium by fasting 
[18F]FDG positron emission/computed tomography (PET/CT) im-
aging alone because the glucose metabolism in the fasting state 
is quite heterogeneous, even in normal myocardium [10, 11]. 
Myocardial glucose utilization increases in many conditions, such 
as myocardial ischaemia, pressure overload, and during exercise; 
myocardial regional ischaemia leads to the translocation of both 
glucose transporters, GLUT 4 and GLUT 1, to the sarcolemma in 
vivo; also, myocardial ischaemia stimulates adenosine monophos-
phate-activated protein kinase, which may increase cardiac glucose 
uptake [12]. Thus, the authors wanted to explore the [18F]FDG 
myocardial uptake patterns in routine overnight fasting oncology 
patients, and it was hypothesized that focal or regional myocardial 
[18F]FDG uptake would be associated with myocardial ischaemia 
on stress single-photon emission CT (SPECT) myocardial perfusion 
imaging (MPI) due to the myocardial metabolic shift from oxidation 
of free fatty acid to glucose uptake. Finally, the authors wanted to 
explore whether the level of blood glucose at the time of injection 
of [18F]FDG would have any influence on the myocardial [18F]FDG 
uptake. 
Material and methods
Population and study design 
This retrospective study was approved by the hospital insti-
tutional review board. Subjects who underwent both oncological 
PET/CT and stress SPECT MPI within 3 months of each other 
were identified through a search of the radiology and cardiology 
database for appropriate clinical indications between January 2017 
and December 2019. Ten patients were excluded because they had 
a focal-mass-like [18F]FDG myocardial uptake raising the suspicion 
of cardiac metastasis or tumour involvement; this needed further 
correlative imaging with other imaging modalities, such as echo-
cardiography or cardiac magnetic resonance imaging. A stress/rest 
SPECT MPI was performed for clinically appropriate indication per 
referring physicians such as symptomatic patients with chest pain 
and high-risk patients undergoing major surgery for pre-opera-
tive risk stratification. Also, patients with established CAD, such 
as patients with prior myocardial infarction, prior coronary artery 
bypass surgery (CABG), or prior percutaneous coronary interven-
tion (PCI), were excluded. 
[18F]FDG PET/CT imaging 
All patients fasted overnight before the PET/CT studies. For 
imaging, 370–740 MBq (10–20 mCi) of [18F]FDG was injected 
intravenously, and scanning started 60 minutes later. No intra-
venous contrast was administered. The studies were conducted 
on a hybrid PET/CT scanner (GE, Discovery, Wisconsin, USA). 
All patients were in a supine position. CT images were acquired 
from the head to mid-thigh using the following standard parameters: 
10 Kvp; current, 180 mA; pitch, 0.981:1; and single round tube 
rotation, 0.85. CT data were used for attenuation correction and 
PET images were reconstructed using ordered-subsets expectation 
maximization (OSEM); 2 iterations, 20 subsets, and a matrix size 
of 128 × 128 pixels were used in the reconstruction. To assess the 
myocardial [18F]FDG uptake, the images were reconstructed with 
attenuation correction, reoriented, and displayed in traditional car-
diac planes (short axis, vertical long axis, and horizontal long axis) 
for interpretation; the myocardial [18F]FDG uptake was classified 
into the four following patterns: pattern 1, completely absent or mild 
myocardial [18F]FDG uptake (Fig. 1a); pattern 2, diffuse (moderate 
or intense) myocardial [18F]FDG uptake (Fig. 1b); pattern 3, patchy 
or multifocal myocardial [18F]FDG uptake (Fig. 1c); and pattern 4, 
focal or regional myocardial [18F]FDG uptake (anterior and septal 
myocardial [18F]FDG uptake, lateral wall myocardial [18F]FDG up-
take, or inferior wall myocardial [18F]FDG uptake (Fig. 1d). 
Stress SPECT MPI acquisition and analysis
Patients underwent rest-stress myocardial perfusion imaging 
studies with either two-conductive separate day or low-dose 
high-dose same-day protocol. The acquisition parameters and 
post-processing were performed according to the guidelines of 
the American Society of Nuclear Cardiology (ASNC) for nuclear 
cardiology procedures [13]. The images were analysed in consen-
sus by experienced nuclear medicine physicians in short, vertical, 
and horizontal views utilizing Auto SPECT (Cedars-Sinai Medical 
Center, Los Angeles, California). A reversible defect was defined 
as a perfusion defect on stress images that partially or completely 
reversible on rest images in two or more contiguous segments. 
A fixed perfusion defect was defined as a perfusion defect on 
stress images in two or more contiguous segments that persist 
on rest images. An abnormal perfusion scan was taken to indicate 
the presence of a reversible or fixed defect or both. Finally, gated 
short-axis images were processed with quantitative SPECT soft-
ware, to measure the ejection fraction. In the visual analysis, the 
17 segments were scored for perfusion defects on a 4-point system 
(0 = normal; 1 = mild; 2 = moderate; and 3 = severe), for both the 
stress and rest images. The perfusion defects based on perfusion 
scores at stress and rest were used to form the final interpretation of 
the studies. Perfusion abnormalities in the apical, anterior wall and 
septal perfusion defect were considered left anterior descending 
(LAD) artery territory; a lateral wall defect indicated left circumflex 
(LCX) artery territory, and an inferior wall perfusion defect indicated 
right coronary artery (RCA) territory.
Statistical analysis
Statistical analysis was performed using SPSS version 20 (IBM, 
USA). Continuous variables were reported as means ± standard 
deviation, and categorical variables were reported as percentages. 
Group means were compared using the t-test, and the association 
between categorical variables was assessed using the Chi-square 
test. Binomial logistic regression was performed to ascertain the 
effects of age, sex, hypertension, hypercholesterolemia, tobacco 
smoking, left ventricular ejection fraction, myocardial [18F]FDG 
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uptake, and abnormal SPECT MPI. Cohen’s K was run to determine 
if there was an agreement between focal/ regional myocardial FDG 
uptake and the presence of ischaemia on myocardial stress SPECT 
in 9 patients. The Type I error rate was set at 5%.
Results 
Baseline characteristics of study subjects 
A total of 362 subjects were included in the study; the average 
age was 65 ± 10-years, and 219/362 (60.5%) patients were male. In 
addition, the mean blood glucose level at the time of FDG injection 
was 104 ± 36 mg, and the mean left ventricular ejection fraction 
was 57 ± 9%. Furthermore, 24.3% 91/362 (25%) patients had 
abnormal SPECT MPI consistent with stress-induced myocardial 
ischaemia. Among the study subjects, 210/362 (58%) patients were 
hypertensive, 195/362 (53%) were diabetic, 42/362 (12%) smoked, 
and only 5/362 (1.4%) had a positive family history of CAD (Tab. 1). 
Type of cancer and oncological indication for FDG PET/CT are 
summarized in Table 2.
Table 1. Patient characteristics (N = 362)




Age, years ± SD 65 ± 10
CAD risk actors 
Hypertension 210 (58%)
Diabetes mellitus 195 (54%)
Hypercholesterolemia 68 (16%)
Smoking 42 (11.6%)
Family history of CAD 5 (1.4%)
LVEF%, mean ± SD 57 ± 9
Mean blood Glucose at the injection of 
[18F]FDG mmol/L ± SD 
104 ± 36
Abnormal SPECT, number, % 91 (25%)
CAD — indicates coronary artery disease; [18F]FDG — fluorodeoxyglucose; LVEF — left 
ventricular ejection fraction; SD — standard deviation; SPECT — single-photon emission 
computed tomography 
Figure 1. Selected axial [18F]FDG PET images demonstrating four patterns of myocardial FDG uptake; A. Completely absent myocardial [18F]FDG 
uptake; B. Diffuse intense myocardial [18F]FDG uptake; C. Patchy with focal myocardial [18F]FDG uptake; D. Regional/focal [18F]FDG uptake in the 
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Patterns of myocardial [18F]FDG uptake and its 
relationship with blood glucose level 
The mean blood glucose level was 104 ± 36. Moreover, 220/362 (61%) 
of the study subjects had completely absent or mild [18F]FDG myo-
cardial uptake, 80/362 (22%) had diffuse myocardial [18F]FDG up- 
take, 39/362 (11%) had patchy or multifocal myocardial [18F]FDG 
uptake, and 23/362 (6%) had regional myocardial [18F]FDG uptake. 
There was no statistically significant association between the glucose 
level and pattern of myocardial [18F]FDG uptake, p = 0.762 (Tab. 3).
Relationship between the pattern of myocardial 
[18F]FDG uptake and myocardial ischaemia on 
stress SPECT MPI 
A significant statistical association was noted between the 
pattern of myocardial [18F]FDG uptake and myocardial ischaemia 
on stress SPECT MPI, p = .025; the most predictive pattern of my-
ocardial [18F]FDG uptake associated with ischaemia was regional 
or focal myocardial [18F]FDG, in 14/23 (39%) patients. The percent-
ages of other patterns observed on stress SPECT MPI were rela-
tively low; for example, the percentage of patients with a complete 
absence of myocardial [18F]FDG uptake was 20%.
Relationship between CAD risk factors and 
myocardial ischaemia on stress SPECT MPI 
There was a statistically significant association between the 
patient age, male gender, hypertension, hypercholesterolemia, 
and tobacco smoking and abnormal SPECT MPI. In contrast, there 
was no association between diabetes mellitus and a history of CAD 
and abnormal SPECT MPI (Tab. 3).
Logistic regression predicting likelihood of SPECT 
based on CAD risk factors, left ventricle ejection 
fraction, and [18F]FDG uptake
Binomial logistic regression was performed to ascertain the 
effects of age, sex, hypertension, hypercholesterolemia, tobacco 
smoking, (left ventricular ejection fraction LVEF), and myocardial 
[18F]FDG uptake on the SPECT results. Of the seven predictive 
variables, only age, hypercholesterolemia, smoking, LVEF, and 
[18F]FDG uptake were associated with abnormal SPECT (Tab. 4).
The agreement between focal myocardial FDG 
uptake and presence of ischaemia on SPECT
Cohen’s K was run to determine if there was an agreement 
between focal/regional myocardial FDG uptake and presence 
of ischaemia on myocardial stress SPECT in 9 patients, there 
was an agreement between 6 patients with focal FDG uptake 
and the presence of ischaemia on SPECT, however, there 
Table 2. Type of oncologic indication for FDG PET/CT study, sample 
study (n = 362)
Type of Malignancy Number Percent [%]




Lymphoma  54 14.9
Others 120 33.1
Total 362 100
Table 3. Baseline characteristics of patients with normal and abnormal SPECT 
Characteristic Overall  
(N = 362)
Patients with normal SPECT 
271




Age, (SD) [y] 65 ± 10 63 ± 10 68 ± 10 0.00001
Male 219 151 68 0.001
Female 143 120 23
Hypertension  210 141 69 0.000
Diabetes mellitus 195 141 54 0.226
Hypercholesterolemia 28 30 58 0.0001
Smoking 42 18 42 0.0001
Family history of CAD 5 2 3 0.070
SPECT               
LVEF [%] 57 ± 9 58 ± 7 51 ± 7   0.0001
[18F]FDG- PET/CT 
Blood glucose level 104 ± 36 104 ± 36 103 ± 7 0.762
Myocardial FDG uptake 0.025
Total Absent 220 175 45
Diffuse uptake 80 53 27
Focal on diffuse uptake 39 29 10
Focal/regional uptake 23 14 9
CAD — indicates coronary artery disease; [18F]FDG — fluorodeoxyglucose; LVEF — left ventricular ejection fraction; SD — standard deviation; SPECT — single-photon emission computed 
tomography
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was a discordant between FDG uptake and ischaemia on 3 pa-
tients. a fair agreement was noted between the FDG uptake and 
presence of ischaemia on SPECT, K = 0.394 (95% CI: 0.164 to 
0.189) (Tab. 4 and 5).
Discussion 
In this study, it was found that up to 61% of overnight fasting 
routine oncology patients had absent to mild myocardial [18F]FDG 
uptake; the remaining 39% of patients had variable physiologi-
cal patterns. No association was found between blood glucose 
level at the time of [18F]FDG intravenous injection and pattern of 
myocardial [18F]FDG uptake, and finally and most importantly, 
a significant statistical association was found between the pattern 
of myocardial [18F]FDG uptake and the presence of myocardial 
ischaemia on stress SPECT MPI; the most significant predictive 
pattern of myocardial [18F]FDG uptake for myocardial ischaemia 
was regional or focal myocardial [18F]FDG uptake. However, the 
agreement between focal or regional FDG uptake and the presence 
of myocardial ischaemia is fair, K = 0.394. Studies have shown that 
the myocardial glucose uptake during fasting is variable, which re-
flects the availability and flexibility of myocardial substrate utilization 
[14, 15]. Among the 362 subjects in this study, 220 subjects had 
completely absent or minimal [18F]FDG uptake; these results were 
consistent with previous studies. 
Understanding myocardial [18F]FDG uptake variability is crucial 
in the interpretation of myocardial viability, cardiac sarcoidosis, and 
[18F]FDG PET/CT studies for the detection of coronary atheroscle-
rosis. Fasting alone cannot explain the variability of myocardial 
metabolism, which may be due in part to the level of substrates, 
such as glucose and free fatty acids; physiological and cellular 
processes, such as myocardial blood flow; and levels of hormones, 
such as insulin, glucagon, dopamine and thyroxine [3]. One study 
showed that ageing, left ventricular hypertrophy, diabetes mellitus, 
and obesity cause alterations in substrate metabolism of either 
glucose or fatty acids [16]. In addition, hypertensive patients with 
increased cardiac workload may have a metabolic shift favouring 
glucose oxidation over fatty acids [17].
Our study showed that, despite overnight fasting, 39% of the 
study subjects had different physiologic patterns of myocardial 
[18F]FDG uptake. This finding is somewhat consistent with the 
results of another study, in which 38% of enrolled individuals still 
demonstrated physiological myocardial [18F]FDG uptake despite 
prolonged fasting of up to 18 hours [18]. A high-fat, low-carbohy-
drate diet may facilitate the switching of the myocardial substrate 
metabolism from glucose to fatty acids [14, 19]. Despite these 
results, the optimum dietary manipulation before [18F]FDG PET/CT 
study for certain indications, such as evaluation of cardiac sarcoido-
sis, has not been defined or standardized [20].
Our study showed a significant association between the 
[18F]FDG myocardial uptake pattern and the presence of myocardial 
ischaemia on stress SPECT MPI, particularly in terms of regional or 
focal myocardial [18F]FDG. Studies have shown that CAD is asso-
ciated with left ventricular uptake in oncology patients in a fasting 
state; the association between myocardial ischaemia and regional 
myocardial [18F]FDG uptake is due to stimulation of glycolysis and 
suppression of fatty acid oxidation by the ischaemic myocardium 
[21]. This metabolic shift is a prerequisite for continued energy 
production and cell survival. It appears that these alterations in the 
myocardial substrate may persist after the resolution of myocardial 
ischaemia in so-called ischaemia memory [22, 23]. One study sug-
gested that this metabolic fingerprint appears superior to perfusion 
imaging for the detection of CAD and assigning a prognosis in pa-
tients with established CAD, and metabolic imaging with [18F]FDG 
or [123I]beta methyl-P-iodophenyl pentadecanoic acid ([123I]BMIPP) 
has been used for ischaemia detection during stress testing [24–27]. 
However, despite these promising studies about metabolic imaging 
for the detection of myocardial ischaemia, several questions re-
main to be answered, such as the optimal imaging protocol and 
a significant amount of diagnostic or prognostic data obtained 
from these metabolic studies that might alter patient management. 
Nevertheless, these results suggest that patients with regional my-
ocardial [18F]FDG uptake at a relatively increased risk of myocardial 
ischaemia compared with other patterns, such as diffuse uptake 
or minimal [18F]FDG uptake, may benefit from further testing with 
stress SPECT MPI to diagnose myocardial ischaemia. 
Study limitations
Our study is retrospective, and it has some limitations. The 
number of enrolled subjects was relatively small, which weakens the 
strength of the presented findings, especially for patients with 
regional [18F]FDG uptake and positive SPECT MPI for myocardial 
Table 4. Logistic regression predicting the likelihood of SPECT based 
on CAD risk factors, LVEF, and [18F]FDG uptake 
p-value Odds ratio 95% confidence interval 
of odds ratio 
Lower Upper
Age 0.012 1.039 1.009 1.070
Sex 0.45 0.519 0.273 0.966
Hypertension 0.055 0.534 0.882 1.014
Hypercholeste- 
rolemia 
0.000 0.258 0.126 0.526
Smoking 0.000 0.233 0.105 0.514
LVEF 0.000 0.924 0.897 0.953
FDG uptake 0.023 1.405 1.049 1.881
CAD — indicates coronary artery disease; [18F]FDG — fluorodeoxyglucose; LVEF — left 
ventricular ejection fraction; SD P-value standard deviation; SPECT — single-photon 
emission computed tomography
Table 5. The agreement between Focal myocardial [18F]FDG uptake 




FDG uptake and 
Ischaemia 
Discordant FDG 
uptake and  
no ischaemia 
LAD 4 3 1
LCX 2 1 1
RCA 3 2 1
Total 9 6 3
[18F]FDG — fluorodeoxyglucose; LAD — left anterior descending coronary artery; LCX 
— left circumflex artery; RCA — right coronary artery; SPECT — single-photon emission 
computed tomography
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ischaemia. Although the research looked at 362 patients who 
underwent both oncological PET/CT and stress SPECT MPI within 
3 months, despite this limitation, the present finding is worth noting 
because it is the first study comparing the correlation of myocar-
dial [18F]FDG uptake in oncological patients and the presence of 
myocardial ischaemia on stress SPECT MPI. The stress SPECT 
MPI results were not correlated with other cardiac imaging studies, 
such as those involving invasive coronary angiography or coronary 
CT angiography. The duration of overnight fasting in hours was not 
reported, since this variable was not controlled. The documented 
information in the chart was reviewed, but clearly, the duration of 
fasting could be quite variable from one patient to another. Finally, 
the myocardial [18F]FDG uptake was evaluated visually and not 
quantitatively because the myocardial [18F]FDG location and se-
verity were evaluated. 
Conclusions
Based on the presented findings, the physiological myocardial 
[18F]FDG uptake in overnight fasting oncology patients is quite 
variable. While a complete absence or minimal [18F]FDG uptake 
is the commonest pattern, the variability may affect the interpretation 
of cardiac sarcoidosis involvement or myocardial viability studies. 
Thus, further dietary manipulation and/or extended prolonged 
fasting before these studies must be considered. The regional 
myocardial FDG uptake pattern is the commonest pattern associ-
ated with myocardial ischaemia on stress SPECT MPI. However, 
there was a fair agreement between the focal FDG myocardial 
FDG uptake and the presence of ischaemia on SPECT. Therefore, 
patients with regional FDG uptake on oncological PET/CT may 
benefit from additional studies to exclude myocardial ischaemia. 
Exploration of the relationship between regional [18F]FDG uptake 
and myocardial ischaemia must be explored in a larger cohort 
to determine the relationship between variable myocardial FDG 
uptake in overnight fasting oncologic patients and the presence 
of ischaemia on SPECT MPI. 
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